Conversely, patients with positive anti-MDA5 antibodies require early and aggressive combination therapy with GCs, calcineurin inhibitors, and IVCY; however, many patients still succumb to respiratory failure within a few months despite treatments [8]. This evidence concerns the gene IFIH1 and respiratory failure.